◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
易明医药 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016FY 2015Dec 31, 2015FY 2014Dec 31, 2014FY 2013Dec 31, 2013
+Revenue 652.0M 667.0M 857.0M 725.0M 603.0M 553.0M 489.0M 380.0M 452.0M 347.0M 291.0M 221.0M
Revenue Growth % -2.2% -22.2% 18.2% 20.2% 9.0% 13.1% 28.7% -15.9% 30.3% 19.2% 31.7% --
Total Revenue 652.0M 667.0M 857.0M 725.0M 603.0M 553.0M 489.0M 380.0M 452.0M 347.0M 291.0M 221.0M
Cost Of Revenue 205.0M 326.0M 481.0M 465.0M 386.0M 371.0M 333.0M 109.0M 132.0M 107.0M 102.0M 90.8M
+Gross Profit 447.0M 341.0M 376.0M 260.0M 217.0M 182.0M 156.0M 271.0M 320.0M 240.0M 189.0M 130.2M
Gross Margin % 68.6% 51.1% 43.9% 35.9% 36.0% 32.9% 31.9% 71.3% 70.8% 69.2% 64.9% 58.9%
Total Operating Cost 624.0M 659.0M 826.0M 700.0M 581.0M 533.0M 491.0M 338.0M 405.0M 302.0M 261.0M 207.0M
Selling Expenses 341.0M 247.0M 271.0M 173.0M 143.0M 111.0M 99.0M 182.0M 215.0M 156.0M 123.0M 82.6M
Admin Expenses 49.4M 51.0M 47.2M 45.9M 35.4M 36.5M 33.0M 32.3M 40.2M 31.9M 28.6M 32.7M
Rd Expenses 15.5M 13.7M 13.4M 11.4M 6.8M 5.0M 16.4M 3.6M -- -- -- --
Finance Expenses -1.2M -1.5M -1.6M -1.1M 663,400 2.2M 839,800 -217,100 4.9M 1.1M 1.5M -217,200
+Operating Income 61.5M 23.5M 55.7M 48.6M 43.1M 47.7M 26.9M 65.1M 47.2M 45.5M 30.0M 14.2M
Operating Margin % 9.4% 3.5% 6.5% 6.7% 7.2% 8.6% 5.5% 17.1% 10.4% 13.1% 10.3% 6.4%
Non Operating Income 911,900 1.2M 1.8M 3.1M 5.8M 1.9M 2.6M 3.2M 16.5M 11.7M 12.6M 13.1M
Non Operating Expenses 2.0M 1.1M 824,800 1.7M 1.6M 1.9M 513,500 400,700 486,800 1.1M 51,000 1.1M
Investment Income 3.5M 2.3M 1.5M 906,900 546,600 1.1M 3.3M 2.7M 36,600 849,900 405,000 29,400
Asset Disposal Income -44,900 30,700 -- 30,400 -121,600 -- 652,000 98,100 -700.00 -- -- --
Asset Impairment Loss 291,100 19.8M 141,600 -- 123,200 900.00 1.3M 4.1M 5.1M 2.2M 1.3M -1.7M
Other Income 29.8M 13.4M 23.3M 22.5M 21.5M 25.9M 25.0M 19.8M -- -- -- --
Income Before Tax 60.4M 23.6M 56.7M 50.0M 47.3M 47.7M 29.0M 67.9M 63.2M 56.1M 42.5M 26.2M
Income Tax 12.9M 7.9M 10.6M 6.5M 6.3M 10.4M 3.7M 7.4M 7.8M 6.1M 8.7M 4.4M
+Net Income 47.5M 15.7M 46.1M 43.5M 41.1M 37.3M 25.3M 60.5M 55.4M 50.0M 33.9M 21.8M
Net Margin % 7.3% 2.4% 5.4% 6.0% 6.8% 6.8% 5.2% 15.9% 12.2% 14.4% 11.6% 9.9%
Net Income Attributable 45.9M 15.4M 44.1M 42.5M 41.1M 37.3M 25.3M 60.5M 55.4M 50.0M 32.4M 19.7M
Minority Interest 1.5M 339,200 2.0M 996,800 -- -- -- -- -- -- 1.5M 2.1M
Eps Basic 0.25 0.08 0.23 0.22 0.22 0.20 0.13 0.32 0.38 0.37 0.24 --
Eps Diluted 0.25 0.08 0.23 0.22 0.22 0.20 0.13 0.32 0.38 0.37 0.24 --
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016FY 2015Dec 31, 2015FY 2014Dec 31, 2014FY 2013Dec 31, 2013
Cash And Equivalents 427.0M 386.0M 321.0M 183.0M 205.0M 160.0M 239.0M 262.0M 281.0M 38.1M 39.1M 26.5M
Trading Financial Assets -- -- -- -- -- 30.0M -- -- -- -- -- --
Accounts Receivable 39.5M 29.2M 163.0M 36.6M 57.9M 68.4M 82.6M 81.2M 78.8M 50.6M 24.7M 4.5M
Notes Receivable 12.9M 9.1M 7.3M 7.6M 25.4M 4.5M 1.7M 5.1M 13.7M 2.2M 6.9M 2.5M
Notes And Accounts Receivable 52.4M 38.3M 170.0M 44.2M 83.3M 72.9M 84.3M 86.3M 92.5M 52.7M 31.6M 7.0M
Prepayments 1.9M 976,600 6.2M 4.5M 5.3M 3.7M 7.3M 10.7M 21.3M 46.8M 43.3M 7.1M
Inventory 41.1M 59.0M 45.6M 33.6M 20.7M 29.6M 28.7M 34.2M 36.7M 46.5M 30.2M 27.7M
Total Current Assets 528.0M 490.0M 575.0M 362.0M 450.0M 401.0M 464.0M 480.0M 452.0M 208.0M 160.0M 78.1M
Long Term Equity Investment -- 42.6M -- -- -- -- -- -- -- -- -- --
Fixed Assets -- 349.0M 365.0M 377.0M 359.0M 205.0M 192.0M 171.0M 138.0M 135.0M 24.3M 26.2M
Fixed Assets Total 345.0M 349.0M 365.0M 377.0M 359.0M 205.0M 192.0M 171.0M 138.0M 135.0M 24.3M 26.2M
Construction In Progress -- -- -- 2.4M 36.7M 163.0M 6.8M 6.5M 2.0M 436,600 21.1M 29,100
Construction In Progress Total -- -- -- 2.4M 36.7M 163.0M 6.8M 6.5M 2.0M 436,600 21.1M 29,100
Intangible Assets 20.7M 25.9M 31.1M 37.2M 41.5M 32.4M 29.1M 24.2M 25.3M 26.0M 10.9M 8.0M
Long Term Deferred Expenses -- -- 1.8M 3.6M -- -- -- 112,400 272,800 570,700 520,700 278,000
Total Non Current Assets 399.0M 438.0M 443.0M 462.0M 458.0M 435.0M 294.0M 254.0M 194.0M 189.0M 109.0M 75.0M
Total Assets 926.0M 928.0M 1.0B 824.0M 908.0M 835.0M 758.0M 733.0M 646.0M 398.0M 268.0M 153.0M
Short Term Borrowings 22.8M 11.0M 50.1M -- 40.0M 70.0M 40.0M -- 10.0M 10.0M 10.0M --
Accounts Payable 104.0M 106.0M 127.0M 15.7M 16.8M 5.4M 11.2M 8.1M 14.3M 19.3M 5.4M 3.7M
Advance Receipts -- -- -- -- -- 5.3M 7.7M 48.1M 21.2M 31.7M 46.5M 20.8M
Contract Liabilities 3.2M 3.5M 4.2M 9.2M 47.4M -- -- -- -- -- -- --
Total Current Liabilities 175.0M 171.0M 262.0M 99.3M 218.0M 180.0M 138.0M 126.0M 88.9M 107.0M 89.0M 81.4M
Long Term Borrowings -- -- -- -- -- -- -- -- -- 40.0M -- --
Total Non Current Liabilities 5.8M 6.6M 6.3M 5.0M 2.7M 2.9M 1.9M 2.6M 2.0M 42.0M 250,000 --
Total Liabilities 181.0M 178.0M 268.0M 104.0M 221.0M 183.0M 140.0M 129.0M 90.9M 149.0M 89.3M 81.4M
Paid In Capital 191.0M 191.0M 191.0M 191.0M 192.0M 193.0M 190.0M 190.0M 190.0M 142.0M 135.0M 50.0M
Capital Reserve 233.0M 233.0M 233.0M 234.0M 236.0M 241.0M 224.0M 224.0M 224.0M 19.7M 7.9M --
Surplus Reserve 21.9M 20.9M 20.9M 20.5M 19.9M 19.4M 17.6M 16.6M 11.5M 6.2M 2.0M 799,200
Retained Earnings 337.0M 297.0M 301.0M 276.0M 250.0M 217.0M 187.0M 174.0M 130.0M 80.0M 34.2M 14.2M
Minority Equity 6.6M 5.0M 4.7M 2.7M -- -- -- -- -- -- -- 6.6M
Equity Attributable 739.0M 745.0M 745.0M 717.0M 687.0M 652.0M 618.0M 605.0M 555.0M 248.0M 179.0M 65.0M
Total Equity 746.0M 750.0M 750.0M 720.0M 687.0M 652.0M 618.0M 605.0M 555.0M 248.0M 179.0M 71.7M
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016FY 2015Dec 31, 2015FY 2014Dec 31, 2014FY 2013Dec 31, 2013
Cash From Sales 720.0M 891.0M 841.0M 811.0M 716.0M 627.0M 517.0M 543.0M 619.0M 543.0M 472.0M 389.0M
Tax Refunds Received -- -- -- -- 835,900 -- -- -- -- -- -- --
Total Operating Cash Inflow 804.0M 940.0M 953.0M 924.0M 767.0M 681.0M 556.0M 610.0M 655.0M 562.0M 498.0M 410.0M
Cash Paid For Goods 167.0M 334.0M 415.0M 466.0M 373.0M 366.0M 302.0M 153.0M 248.0M 335.0M 282.0M 203.0M
Cash Paid To Employees 69.8M 75.0M 72.6M 59.5M 40.5M 38.7M 50.7M 67.0M 70.8M 59.5M 57.8M 30.9M
Taxes Paid 96.4M 95.3M 86.8M 87.0M 55.6M 65.9M 66.5M 53.6M 76.6M 42.2M 44.6M 27.3M
Total Operating Cash Outflow 692.0M 773.0M 885.0M 814.0M 665.0M 622.0M 542.0M 532.0M 598.0M 591.0M 495.0M 358.0M
Operating Cash Flow 112.0M 167.0M 68.5M 110.0M 102.0M 59.2M 13.3M 77.3M 57.2M -29.7M 2.2M 52.2M
Total Investing Cash Inflow 521.0M 452.0M 201.0M 241.0M 121.0M 386.0M 369.0M 334.0M 33.0M 84.1M 213.0M 16.6M
Total Investing Cash Outflow 502.0M 495.0M 203.0M 295.0M 128.0M 585.0M 433.0M 405.0M 51.5M 122.0M 274.0M 62.1M
Investing Cash Flow 19.0M -43.0M -1.7M -53.7M -7.8M -199.0M -63.5M -70.8M -18.5M -38.0M -61.3M -45.6M
Cash From Borrowings 22.8M 11.0M 50.0M -- 110.0M 70.0M 40.0M -- 10.0M 60.0M 10.0M --
Dividends And Interest Paid 6.0M 20.3M 19.8M 16.1M 9.3M 8.4M 12.8M 11.9M 3.5M 766,300 3.3M 1.8M
Debt Repayments 11.0M 50.0M -- 40.0M 140.0M 40.0M -- 10.0M 60.0M 10.0M 20.0M --
Total Financing Cash Inflow 22.8M 11.0M 50.0M -- 110.0M 88.1M 40.0M 1.1M 276.0M 79.1M 100.0M 5.0M
Total Financing Cash Outflow 67.1M 70.3M 22.4M 59.2M 157.0M 48.4M 12.8M 27.3M 71.7M 12.4M 28.3M 1.8M
Financing Cash Flow -44.3M -59.3M 27.6M -59.2M -46.8M 39.7M 27.2M -26.2M 204.0M 66.7M 71.7M 3.2M
Net Change In Cash 86.5M 64.6M 94.3M -3.4M 47.0M -100.0M -22.9M -19.7M 243.0M -980,600 12.6M 9.9M
Ending Cash Balance 427.0M 341.0M 276.0M 182.0M 185.0M 138.0M 239.0M 262.0M 281.0M 38.1M 39.1M 26.5M
Capex 12.2M 3.2M 3.2M 25.2M 38.4M 170.0M 67.7M 74.6M 18.5M 44.2M 45.1M 28.6M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...